Skip to content
International Cytokine & Interferon Society
Menu
  • About
    • 2020 ICIS Election
    • Leadership
    • Committees
    • Honorary Lifetime Members
    • News
    • Constitution and Bylaws
    • Interferon History Slides
    • About the ICS
    • About the ISICR
    • Contact Us
  • Membership
    • Renew Online
    • Join
    • 2020 Annual Business Meeting
    • New-Member Mini-Bios
    • Cytokine Careers
    • 2020 ICIS Election
    • Announcing the 2020 Election Results
    • Directory of Members
  • ICIS Awards
    • Mid-Career & Senior Researchers
      • Pfizer Award for Excellence in Interferon and Cytokine Research
        • 2020 Milstein Award Winner
      • ICIS – BioLegend William E. Paul Award
        • 2020 BioLegend William E. Paul Award Winners
      • ICIS-Luminex John R. Kettman Award
        • 2020 ICIS-LUMINEX John R. Kettman Award Winner
      • NEW ICIS Mentorship Award
      • ICIS Honorary Lifetime Member Award
      • ICIS Distinguished Service Award
        • 2020 Honorary Lifetime Membership Award Winner
        • 2020 ICIS Distinguished Service Award Winner
      • The Vilcek Prizes
    • ICIS Young Investigator Awards & Abstract Presentation Awards
      • The Sidney & Joan Pestka Graduate & Post Graduate Awards
      • The Christina Fleischmann Award to Young Women Investigators
      • ICIS Amanda Proudfoot Tribute Award
        • Donate
      • Pfizer Trainee Awards
      • 2020 Young Investigator Award Winners
  • Meetings
    • Cytokines 2021 Cardiff
    • Future Meetings
    • Past Meetings
      • Cytokines 2020 Seattle
      • Cytokines 2019 Vienna
      • Cytokines 2018 Boston
      • Cytokines 2017 Kanazawa
    • Other Meetings
    • ICIS Industry Partners
    • History of the Interferons
    • Tips for Talks
  • Publications
    • ICIS Journals
    • Signals+ October 2020
    • Signals+ April 2020
    • Signals+ October 2019
    • Signals+ April 2019
    • Signals+ October 2018
    • Signals+ April 2018
    • Signals+ October 2017
    • Signals+ April 2017
    • Signals+ Past Issues
    • Reviews of Interest
  • Resources
    • COVID-19
      • What is a mRNA vaccine and how do they work?
      • Inflammatory Roles of Cytokines in COVID-19/SARS-CoV-2
      • Introduction to COVID-19 and SARS-CoV-2
      • ICIS – COVID-19 Video Contest
    • Interferon History Slides
    • WWW
    • Web Resources
    • Featured Websites
    • Commercial Resources & Catalogs
    • Recipes
  • Login

Cytokines 2016 Abstract Submissions

Home » Cytokines 2016 Abstract Submissions

16-19 October 2016
Hyatt Regency San Francisco, USA

Abstract Submissions


Abstract submissions are now closed

Submission guidelines

Delegates who would like to present their work at the meeting, either orally or as a poster, are invited to submit an abstract for consideration by the Scientific Committee.

Abstracts are accepted on a wide range of themes including immune regulation of inflammation and cancer, the microbiota and regulation of inflammation, cytokine regulation of cellular metabolism, cytokine signaling and epigenetics, interferons: regulators of immunity and inflammation, innate and adaptive immune mechanisms of host defense, cytokines and metabolic diseases, and other topics.

Please refer to the instructions here below so as to ensure a smooth and successful abstract submission.

The corresponding topic must be selected to ensure correct scoring of the abstract. The content of the abstract must be topic related. The papers will be peer-reviewed and selected for poster or oral presentation.

A paper should not be submitted to the 4th Annual Meeting of the International Cytokine and Interferon Society if the full paper has been already published.

For standardization, the acceptable length of the abstract is of maximum 3’600 characters and 45 lines. This includes the author’s details, titles and non-visible characters, such as spaces and line breaks.

IMPORTANT DATES

Submissions accepted from:10 February 2014
Submission deadline:Wednesday 1st June 2016, 23:59 CET
Notifications to submitters:Early July

Abstracts received after the deadline will not be accepted!

TECHNICAL REQUIREMENTS

The internet abstract submission system works best with Internet Explorer: 8.0 or higher, FireFox: 5.0 or higher, Chrome: 16 or higher. Cookies and JavaScript need to be enabled

GENERAL

Abstracts can only be submitted online via the abstract submission form that can be found in the section “Abstracts” on the official meeting website: www.cytokines2016.com

Abstracts sent by post or email will not be accepted.
No exceptions will be made.

Abstracts can be saved in “Draft” status to be re-edited and modified until the submission deadline (Wednesday 1st June 2016, 23:59 CET). Therefore, the submitter will be required to create a user account.

Abstracts fulfilling all criteria can be saved in “Final submission” status. Only abstracts in “Final submission” status will be regarded as successfully submitted and considered for the meeting. The submitted / draft abstracts cannot be edited after the submission deadline (Wednesday 1st June 2016, 23:59 CET)

The abstract should be structured into the following sections:

  • A title which clearly indicates the nature of the investigation.
  • Introduction should contain 1-2 sentences that clearly indicate the scientific question of the study and its clinical (or other) importance.
  • Methods should contain sufficient information to be able to understand the experimental design, the analytical techniques and the statistics used in the study.
  • Results should contain objective data to answer the scientific question(s).
  • Conclusions should provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralization.
  • No tables or figures can be included in the abstract.

Conflict of interest: It is the intent of Cytokines 2016 to provide high-quality sessions focused on educational content that is free from commercial influence or bias. Thus the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during abstract submission.

Abbreviations should be indicated in parentheses following their first mention in the text. Trade names cannot be mentioned in the title. However, trade names in brackets will be accepted in the body of the text.

The submission of an abstract constitutes a formal commitment by the submitting (presenting) author to present the abstract (if accepted) in the session and the time assigned by the Programme Committee. Registration fees will not be waived.

The presenting author of the abstract must be registered at the meeting within 14 days of confirmation of abstract acceptance (the author will benefit from early bird registration fee).

Please ensure your abstract does not contain spelling, grammar, or scientific mistakes, as it will be reproduced exactly as submitted. Linguistic accuracy is your responsibility. No proof reading will be done. No changes can be made to the abstract after the submission deadline.

After the submission

The reviewers will judge the abstracts according to scientific or clinical value, relevance to Cytokines 2016, conclusions confirmed by objective results, objectivity of statements, originality of work and overall impression.

The submitting authors will be notified by early July at the email address provided during submission whether their abstract has been accepted.

If you need to withdraw your abstract a written statement, reflecting the reasons of this decision must be sent to [email protected] no later than 15 July 2016.

Presentation of abstracts

Abstracts can be accepted either as poster or oral communication.

If your abstract is accepted as a poster, you will be requested to be available for discussion during the corresponding poster viewing session. Details on poster format and full presentation guidelines will be included in the notification letter and posted on the meeting website.

Publication

Accepted abstracts will be available on the Cytokines 2016 website, about one month prior to the meeting and they will be published in the electronic version of abstract book included in the meeting documents provided to registered delegates.

Contacts

For any further enquiries, please contact the Cytokines 2016 Abstract Handling Team at [email protected]

Important dates and deadlines

10 February 2016
Opening of registration

1 June 2016
Early registration deadline

1 September 2016
Late breaking abstract submission

MCI Suisse SA
[email protected]

Privacy Policy

Copyright © 2017 MCI Suisse SA

 1,117 total views,  4 views today

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)

News & Update

  • Accepting Nominations for the NEW ICIS Mentorship Award until April 5th
  • 34th Annual Conference: Macrophages and dendritic cells in infection and inflammation, Virtual Meeting June 24-25
  • Please renew 2021 Membership Dues or join the International Cytokine & Interferon Society (ICIS)!
  • Vilcek Foundation Think Like a Girl Coloring Book of Women Pioneers in STEM
  • 2021 ICIS Member Engagement Campaign!

Contact Us:

International Cytokine & Interferon Society (ICIS)
297 Kinderkamack Road, Suite 348
Oradell, NJ 07649 USA
Tel. 1-800-947-1960
Fax: 1-201-322-1818

Virtual Office of the Managing Director:

Joan Oefner, Managing Director
Regensburg, Germany
Tel: +49 (0) 171-1049-181
Fax: +1-201-322-1818
E-mail

Recent News

  • Accepting Nominations for the NEW ICIS Mentorship Award until April 5th
  • 34th Annual Conference: Macrophages and dendritic cells in infection and inflammation, Virtual Meeting June 24-25
  • Please renew 2021 Membership Dues or join the International Cytokine & Interferon Society (ICIS)!
  • Vilcek Foundation Think Like a Girl Coloring Book of Women Pioneers in STEM

Contact Us

For more information about the Society, please contact our Managing Director, Joan Oefner or fill out the contact form.

International Cytokine & Interferon Society (ICIS)
297 Kinderkamack Road, Suite 348
Oradell, NJ 07649 USA
Tel: 1-800-947-1960
Fax: 1-201-322-1818

Virtual Office of the Managing Director:

Joan Oefner, Managing Director
Regensburg, Germany
Tel. +49 (0) 171-1049-181
FaceTime/WhatsApp: +49 (0) 171-1049-181
Fax: 1-201-322-1818
joefner(a)cytokinesociety.org

Subscribe for Future Announcements

Search

Join our Newsletter
Engage with Us
International Cytokine & Interferon Society, Copyright 2021 Website Design by Rhema Association Management | Privacy Policy
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. You have the option to customize your "Cookie Settings". By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview


This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience. Please view our full privacy policy here: https://cytokinesociety.org/privacy-policy/

Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

SAVE & ACCEPT
Powered by